Gastrointestinal Studies

RESTORATiVE303

EU CT Nummer: 2022-502972-22-00

Recruitment is open

A randomized, double-blind, placebo-controlled phase-3-study of VE303 for prevention of recurrent Clostridioides difficile infection

Objective

Prevention of recurring Clostridium difficile infections

We are looking for patients with :

  • Acute diarrhea (C. Diff.)
  • At least 1 previous C. Diff. infections in the past 6 months

If you are interested in the study, please speak to your GP or specialist doctor. You can also contact us directly by email or via the contact form for more information.